DEA Audit Group (DAG) was founded to prepare DEA registrants nationwide for the recent DEA “surge” formed to combat the opioid crisis. The inspection of pharmacies and practitioners by DEA has resulted in numerous administrative actions and civil fines. Some registrants could face suspension and eventual revocation of their registration and/or criminal charges. Wholesalers and manufacturers could also be affected for a failure to create a "Know Your Customer/Due Diligence Program", or to accurately monitor suspicious orders. The DEA has stated that they will continue to aggressively use this targeting playbook in continuing operations.